Home » Topics » BioWorld Science

BioWorld Science
RSS

BioNTech and Crescendo Biologics partner to develop immunotherapies for cancer and other diseases

Jan. 11, 2022

Targeting aggregated TDP-43 as new strategy for development of ALS and FTLD therapies

Jan. 11, 2022

Acadia and Stroke collaborate on novel RNA-based medicines for neurodevelopmental diseases

Jan. 11, 2022

HotSpot and Caris enter strategic partnership to advance HotSpot's portfolio

Jan. 11, 2022

Carisma and Moderna collaborate to generate and develop in vivo CAR-M therapeutics

Jan. 11, 2022

Tenaya expands heart disease pipeline with selection of TN-401 as development candidate

Jan. 11, 2022

Combination of rifampicin and resveratrol shows promise in models of neurodegenerative dementia

Jan. 11, 2022

Pfizer and Codex DNA collaborate to leverage EDS technology for mRNA-based vaccines

Jan. 11, 2022

Betta Pharmaceuticals discloses new HIF-2alpha inhibitors

Jan. 11, 2022

Surrozen advances research pipeline targeting Wnt pathway

Jan. 11, 2022

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...